PAI
PACB icon

Pittenger & Anderson Inc’s Pacific Biosciences PACB Stock Holding History

Pittenger & Anderson Inc’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-890
Closed -$7.43K – 446
2023
Q3 		$7.43K Hold
890
– – ﹤0.01% 364
2023
Q2 		$11.8K Buy
890
+115
+15% +$1.4K ﹤0.01% 351
2023
Q1 		$8.97K Buy
775
+542
+233% +$5.39K ﹤0.01% 361
2022
Q4 		$1.91K Hold
233
– – ﹤0.01% 409
2022
Q3 		$1K Hold
233
– – ﹤0.01% 438
2022
Q2 		$1K Hold
233
– – ﹤0.01% 425
2022
Q1 		$2K Hold
233
– – ﹤0.01% 429
2021
Q4 		$5K Hold
233
– – ﹤0.01% 398
2021
Q3 		$6K Buy
233
+33
+17% +$978 ﹤0.01% 386
2021
Q2 		$7K Hold
200
– – ﹤0.01% 344
2021
Q1 		$7K Sell
200
-125
-38% -$4.38K ﹤0.01% 331
2020
Q4 		$8K Buy
325
+30
+10% +$510 ﹤0.01% 319
2020
Q3 		$3K Buy
+295
New +$1.7K ﹤0.01% 337

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Pittenger & Anderson Inc's PACB Position: Q4 2023 in Review

Pittenger & Anderson Inc sold out of Pacific Biosciences (PACB) in Q4 2023, closing a stake of 890 shares — an estimated $7.43K sold.

Pittenger & Anderson Inc first reported a position in PACB in Q3 2020 and held it in 13 quarters. The position peaked at $11.8K in Q2 2023. 274 funds tracked by Wall St. Rank hold PACB as of Q4 2023.

  • Pittenger & Anderson Inc reported no remaining Pacific Biosciences position as of Q4 2023 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 890 Pacific Biosciences shares in Q4 2023, an estimated $7.43K.
  • Pittenger & Anderson Inc first reported a position in Pacific Biosciences in Q3 2020 and held it in 13 quarters.
  • Pittenger & Anderson Inc's Pacific Biosciences position peaked at $11.8K in Q2 2023.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2023.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2023, filed 2 Feb 2024.